Ron Finklestien
Stock Market Surges and M&T Bank Falters in Q4 Financials
Towards the end of Thursday’s trading session, U.S. stocks surged, with the Dow Jones index gaining over 100 points. The Dow increased by 0.35% ...
Significant Volatility Expected in Stock Market
The Window Opens
The stock market has been experiencing a lull since the end of 2023, setting the stage for a potential significant pullback. The coming expiration ...
Harsh Weather Freezes U.S. LNG Flows, Disrupting Shipments
Harsh Weather Freezes U.S. LNG Flows, Disrupting Shipments
lyash01/iStock via Getty Images As a brutal cold front sweeps across Texas and Louisiana, it has thrown a spanner in the works for U.S. ...
Compelling Reasons to Hold on to Corebridge (CRBG) Stock Now
Corebridge: A Stock Set to Soar
Corebridge Financial, Inc. CRBG is aided by growing premiums attributable to a diversified product suite and new business growth. Partnerships, strong segmental contribution and ...
The Financial Rollercoaster: KeyCorp Shares Plunge Over 5% Following Fourth-Quarter Report
KeyCorp shareholders were sent on a gut-wrenching financial rollercoaster Thursday as they watched shares plummet over 5% after the company’s distressing fourth-quarter financial report. ...
Impinj’s Prospects Brighten After Analyst Ups Price Target on RFID Expansion
Impinj’s Prospects Brighten After Analyst Ups Price Target on RFID Expansion
Analyst’s Bright Outlook Needham analyst James Ricchiuti raised the price target of Impinj Inc (PI) to $115 from $85 while maintaining a Buy rating. ...
Reconsidering British American Tobacco Stock
Reconsidering Brian American Tobacco Stock: A Critical Evaluation
British American Tobacco (NYSE:BTI) is often portrayed as a golden opportunity for income-focused investors. The company boasts a defensive business model, a towering dividend ...
State Street’s Strategic Shift in Digital Assets Division
State Street’s Strategic Shift in Digital Assets Division
yongyuan/iStock via Getty Images State Street Corp. (NYSE:STT) is in the midst of a significant realignment within its digital-assets unit. The reorganization, which includes ...
Is Intellia (NTLA) Stock a Smart Investment Now?
Is Intellia (NTLA) Stock a Smart Investment Now?
Intellia Therapeutics, Inc. NTLA is a clinical-stage genome editing company that focuses on developing CRISPR/Cas9-based therapeutics. The company’s pipeline includes NTLA-2001 for treating transthyretin ...
Positive Momentum for Crude Oil and Processa Pharmaceuticals
Positive Momentum for Crude Oil and Processa Pharmaceuticals
U.S. stocks maintain momentum, with the Nasdaq Composite gaining over 1% on Thursday. The Dow traded down 0.02% to 37,257.79 while the NASDAQ rose ...
